Scienture Holdings, Inc.
For the period ended Dec 31, 2025. Filed Mar 30, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 30, 2026
SCNX$3.20+2.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
CONSOLIDATED STATEMENTS OF OPERATIONS
Years Ended December 31, 2025 and 2024
| Year Ended | |||
|---|---|---|---|
| December 31, | |||
| 2025 · 2024 | |||
| Revenues | $431,609 | $136,643 | |
| Cost of sales | 100,127 | 130,638 | |
| Gross profit | 331,482 | 6,005 | |
| Operating expenses: | |||
| Wage and salary expense | 2,118,568 | 2,111,066 | |
| Professional fees | 2,407,822 | 1,458,332 | |
| Accounting and legal expense | 2,070,337 | 1,807,041 | |
| Technology expense | 97,261 | 416,311 | |
| General and administrative | 7,926,016 | 6,677,580 | |
| Research and development | 1,956,270 | 2,236,690 | |
| Impairment loss | 26,346,050 | - | |
| Total operating expenses | 42,922,324 | 14,707,020 | |
| Operating loss | (42,590,842) | (14,701,015) | |
| Non-operating income (expense): | |||
| Change in fair value of warrant liability | 909,020 | (182,982) | |
| Change in fair value of derivative liability | 2,296,834 | 180,383 | |
| Impairment of investment | - | (2,500,000) | |
| Loss on conversion of note payable | (53,446) | - | |
| Loss on disposition of subsidiaries | (288,204) | - | |
| Interest income | 302,702 | 135,337 | |
| Loss on disposal of asset | - | (374,968) | |
| Interest expense | (4,083,206) | (1,335,631) | |
| Total non-operating expense | (916,300) | (4,077,861) | |
| Net loss from continuing operations | (43,507,142) | (18,778,876) | |
| Benefit / (provision) for income taxes | 1,994,878 | 534,396 | |
| Net loss from continuing operations, net of tax | (41,512,264) | (18,244,480) | |
| Net income from discontinued operations, net of tax | - | 27,310,278 | |
| Net (loss) income | $(41,512,264) | $9,065,798 | |
| Net loss per common share from continuing operations | |||
| Basic | $(2.70) | $(5.41) | |
| Diluted | $(2.70) | $(5.41) | |
| Net income per common share from discontinued operations | |||
| Basic | $ | - | $8.09 |
| Diluted | $ | - | $7.47 |
| Net (loss) income per common share | |||
| Basic | $(2.70) | $2.69 | |
| Diluted | $(2.70) | $2.48 | |
| Weighted average common shares outstanding | |||
| Basic | 15,347,312 | 3,375,325 | |
| Diluted | 15,347,312 | 3,653,609 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.